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ABSTRACT: A captive striped skunk (Mephitis
mephitis) study was conducted between Feb-
ruary and June 2004 at the United States
Department of Agriculture, Animal and Plant
Health Inspection Service, Wildlife Services
National Wildlife Research Center, Fort Col-
lins, Colorado, USA. The main objective was to
determine the percentage of adult striped
skunks that were marked after consuming
placebo oral rabies vaccine (ORV) baits con-
taining 100 mg of an experimental microen-
capsulated (coated microparticle) tetracycline
hydrochloride biomarker. Biomarkers were
identified in the canine teeth and mandibles
of five of five skunks that consumed an ORV
bait. A second objective was to determine if the
microencapsulated tetracycline was resistant to
photochemical conversion from tetracycline to
epitetracycline. After 15 days of exposure,
conversion from tetracycline to epitetracycline
concentration in the microencapsulated prod-
uct (mean 1.9% conversion, SD51.24) was
significantly less (P50.006) than the pure-grade
tetracycline powder (mean 7.5% conversion,
SD51.37). Results support the use of micro-
encapsulated tetracycline hydrochloride as a
biomarker in circumstances where the use of
conventional powdered tetracycline hydrochlo-
ride is not feasible due to ORV bait design
constraints.
Key words: Coated sachet, Mephitis me-
phitis, oral rabies vaccination, pen study,
striped skunk, tetracycline biomarker.
Oral rabies vaccine (ORV) baits typical-
ly contain tetracycline hydrochloride as a
biomarker (Johnston and Tinline, 2002).
The tetracycline biomarker becomes in-
corporated into the teeth and bones of
animals that consume the ORV baits
(Johnston et al., 1999). These permanent
marks in the teeth allow ORV program
coordinators to evaluate baiting success by
trapping animals within an ORV zone,
extracting a tooth from each individual for
tetracycline analysis, and determining the
number of target animals that have
consumed one or more baits. Discrepan-
cies between biomarker and vaccination
levels in the target population allow ORV
programs to discover potential problems
with a particular vaccine lot, or the ORV
bait itself. Biomarker data can also be used
to optimize ORV program strategies by
comparing bait consumption in the target
species to variation in baiting density and
flight line intervals (Johnston and Tinline,
2002).
The United States Department of Agri-
culture (USDA), Animal and Plant Health
Inspection Service (APHIS), Wildlife Ser-
vices (WS) ORV Program currently uses
an extruded fish-meal polymer bait (FMP;
MERIAL Ltd., Athens, Georgia, USA)
that contains 150 mg of tetracycline
hydrochloride as a biomarker (Slate et
al., 2005). The relatively large volume of
the FMP allows for the tetracycline
biomarker to be added as a powder to
the bait material before extrusion. This
allows for homogeneous mixing of the
biomarker throughout the bait (Johnston
et al., 2005) and may mask or dilute the
bitter taste (del Castillo et al., 2002) of the
tetracycline hydrochloride powder. MER-
IAL Ltd. also manufactures a coated
sachet (CS) bait that utilizes the same
vaccine sachet as the FMP, but has a
minimal fish-meal coating that does not
contain a biomarker. The CS bait has
shown promise in raccoons (Procyon lotor)
and coyotes (Canis latrans; Linhart et al.,
2002), in captive bait acceptance trials in
skunks (Mephitis mephitis; Jojola et al.,
2007), and is currently used in the WS
ORV Program as an alternative to the
FMP bait for vaccinating raccoons. Un-
fortunately, skunks have proven difficult to
1024
vaccinate, as indicated by poor serocon-
version rates within ORV zones (Rosatte,
2008). Grosenbaugh et al. (2007) found
that four of four of skunks that serocon-
verted after direct oral installation of
Raboral V-RGH survived a rabies chal-
lenge. Ten skunks in the same study did
not develop rabies virus–neutralizing an-
tibodies after consumption of either one
or three CS baits containing Raboral V-
RGH, and nine of these ten skunks died
upon rabies challenge. These results
suggest that the CS bait is not delivering
the vaccine to striped skunks effectively
during consumption, and that improved
ORV baits need to be developed for use in
skunks. Rosatte et al. (2008) attributed
these low seroconversion rates skunks in
Canada to CS baits having been designed
for raccoons and other larger animals.
Jojola et al. (2004) suggest that smaller
baits would allow skunks to puncture the
vaccine container more easily.
Smaller ORV baits intended for skunks
would still require adequate tetracycline
biomarker concentrations (.80 mg). The
higher ratio of tetracycline to bait material
on these improved smaller bait designs
may result in palatability issues if tetracy-
cline hydrochloride powder is used. In an
effort to improve palatability and field
stability of the tetracycline biomarker, an
experimental microencapsulated tetracy-
cline was developed at the USDA APHIS
WS National Wildlife Research Center
(NWRC), Fort Collins, Colorado, USA.
The microencapsulation process coats
small particles of tetracycline with a
polymer and results in a tasteless granular
product, similar to sustained-release phar-
maceutical products.
To produce the microencapsulated tet-
racycline used in this study, tetracycline
hydrochloride (500 g) and Avicel 101
(100 g; microcrystalline cellulose tableting
material; FMC Corporation, Philadelphia,
Pennsylvania, USA) were placed in a
Kitchen-Aid mixing bowl and 30 g of
Kollidon 30 (a binding agent; BASF,
Florham Park, New Jersey, USA) in
300 mdl of water was slowly added with
mixing. The wetted mass was pushed
through a No. 7 sieve and the pieces were
dried in a 60-C oven to 1–3% moisture.
This material was force sieved through a
series of sieves and the fraction of particles
smaller than No. 20 and greater than
No. 40 sieves in size were retained. The
remaining particles were reworked
through the wet sieve granulation steps
until all were of the same approximate
size. Based on the particle size (,0.8 mm)
and a desired coating level of 0.2 mg/cm2,
a coating level of 20% was determined.
The coating consisted of EPO (an amine-
substituted polyacrylate; Rohm Pharma
Polymers, Piscataway, New Jersey, USA),
acetyltriethyl citrate (coating plasticizer;
Morflex Inc., Greensboro, NC, USA) and
sodium dodecyl sulfate (surfactant; Sigma
Chemical Co., St. Louis, Missouri, USA)
dispersed in water. Using a fluidizing bed
coating machine (Strea-1; Aeromatic-
Fielder, Eastleigh, Hampshire, UK), the
coating suspension was sprayed onto the
particles with an inlet temperature of
40 C, outlet temperature of 28 C, and
an application rate of approximately
5 ml/min. The resulting microencapsulat-
ed tetracycline concentration was approx-
imately 72% tetracycline by weight (68%
tetracycline and 4% epitetracycline).
To test the microencapsulated tetracy-
cline’s ability to prevent photoconversion
of tetracycline to epitetracycline, three 1-g
replicates of the product and three 1-g
replicates of a technical-grade tetracycline
powder were placed in an environmental
chamber for 15 days. The environmental
chamber conditions were set for periods of
12 hr of light and 12 hr of dark per day.
The light period conditions averaged 28 C
with an average relative humidity of 55%.
The dark period conditions averaged 20 C
with an average relative humidity of 65%.
The radiant energy of the daylight period
was monitored with a radiometer (UVX
Digital Radiometer, UVP, Inc, Upland,
California, USA) with three different
sensors. The three sensors (R-25 254 nm,
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R-31 310 nm, and R-36 365 nm) averaged
11.5, 27.0, and 52 mW/cm2. The same
three sensors measured 8.6, 32.6, and
21.5 mW/cm2 respectively in natural light
during a cloudy day on 25 May 2005 at the
NWRC. The tetracycline concentration of
the microencapsulated product versus the
technical-grade tetracycline was analyzed
by removing three 5-mg samples every
third day from the environmental cham-
ber. All samples were immediately ana-
lyzed according to high-performance liq-
uid chromatography protocols established
for tetracycline analysis at the NWRC
(Primus et al., 2005). All percent tetracy-
cline values for each sample were arc sine
transformed to allow student t-test com-
parisons between microencapsulated and
tech-grade tetracycline replicates after
environmental chamber exposure. Stu-
dent’s t-test was performed with the use
of the TTEST formula in Excel 2007.
Experimental placebo CS baits were
produced by mixing the microencapsulat-
ed tetracycline with the standard fish-meal
coating bait material. This mixture was
then applied to the exterior of the sachet
so that the resulting CS bait contained
100 mg (80 mg of tetracycline + 20 mg
coating and clumping materials) of the
microencapsulated product. There were
no observed differences in the durability
of the coating of regular sachets versus
sachets with the added microencapsulated
tetracycline. A second bait type, the
Artemis (Artemis Technologies, Inc.
Guelph, Ontario, Canada) blister packs
(AB) were prepared in the same manner.
Twenty individually housed skunks
were retained from a previous study
between February and June 2004 and
were fed a diet consisting of 100 g Mazuri
Omnivore Zoo Feed ‘‘A’’ daily and water
ad libitum. Ten skunks were given the
opportunity to consume a single placebo
CS bait containing 100 mg of the micro-
encapsulated tetracycline on its exterior.
Ten additional skunks were given the
opportunity to consume a single placebo
Artemis blister pack to which fish-meal
crumbles and 100-mg microencapsulated
tetracycline had been added. Each skunk
was given a single bait to consume on a
given night. One hour after sunset, the
bait was placed in the center of a plate and
the next morning any remaining parts of
the bait were examined. All baits included
80 mg of active tetracycline, which is at
least two times the amount of tetracycline
needed to biomark an average-sized (4 kg)
adult striped skunk (10 mg tetracycline/kg
body weight; Johnston et al., 1999). There-
fore, any bait remnant that was visually
observed to be missing over 50% of the bait
coating was classified as a potentially
successful biomarking. Each skunk was
allowed to consume only one bait. All
skunks that successfully consumed a bait
remained on test for a minimum of 8 wk to
allow the tetracycline biomarker, if present,
to be more easily discerned in the teeth and
jaw tissues. All skunks were then eutha-
nized and a transverse section was taken
through the mandible and canine tooth
root for biomarker analysis. The tetracy-
cline biomarker analyses were performed
at the NWRC according to established
protocols (Johnston and Watt, 1981; John-
ston et al., 1999).
Epitetracycline formation during the
extrusion process of the FMP bait has
been shown to result in a decrease in the
bait’s marking potential (Johnston et al.,
2005). To maintain optimum biomarking
efficiency, ORV bait designs should min-
imize conversion of tetracycline to epitet-
racycline both during the manufacturing
process as well as environmental exposure
when distributed in the field. After 15 days
of exposure, conversion from tetracycline
to epitetracycline concentration in the
microencapsulated product (mean 1.9%
conversion, SD51.24) was significantly
less (P50.006) than the pure-grade tetra-
cycline powder (mean 7.5% conversion,
SD51.37). The microencapsulated mate-
rial affords substantial protection from
photochemical conversion of tetracycline
to epitetracycline in a simulated natural
light environment.
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The main objective of this study was to
determine the efficacy of the experimental
microencapsulated tetracycline in bio-
marking captive adult striped skunks. Five
of 20 skunks successfully consumed an
ORV bait before the study was concluded.
The 25% bait acceptance rate may have
been influenced by the fact that these
skunks had been in captivity for 4–6 mo
before the experiment began and were
well fed and accustomed to the captive
diet. These five individuals ranged be-
tween 3.2 and 5.3 kg in body weight. One
male and one female skunk successfully
consumed 100% of the CS bait and two
male skunks consumed 75% and 50% of
their CS baits, respectively. Only one
female skunk consumed 75% of an AB
bait. All five of the skunks were positive
for the tetracycline biomarker in the
canine tooth cementum layer and sur-
rounding mandibular bone tissue.
There were no apparent differences in
the strength of the tetracycline signatures
in the teeth and bone tissues, despite the
differences in the amount of bait and
biomarker consumed and the weights of
the skunks as confounding factors. These
results suggest that 100 mg of the
microencapsulated tetracycline per bait is
sufficient to mark adult striped skunks of
both sexes in a field setting. Ideally, a
single ORV bait would be efficacious in all
target species. If such a bait were designed
with the use of this microencapsulated
tetracycline, controlled pen studies would
be warranted to examine the biomarking
capability of this microencapsulated tetra-
cycline hydrochloride in all age classes and
species of skunks as well as other ORV
target species such as raccoons, coyotes,
and gray foxes (Urocyon cinereoargen-
teus). There is supporting evidence that
the microencapsulated tetracycline used
in this study will biomark raccoons in a
field setting. A study conducted by the
first author in Louisiana in which CS baits
containing 100 mg microencapsulated
tetracycline were distributed into the
environment at a density of 75 baits/km2
indicated that 57% (eight of 14) of
raccoons captured were positive for the
tetracycline biomarker. The number of
individual raccoons that actually con-
sumed a bait and the background levels
of fluorescence in this population is
unknown, however.
The authors thank Dr. Gordon Gath-
right and the NWRC animal care staff for
their support during the study, Merial
Limited and Artemis Technologies, Inc.
for providing bait materials, Susan Jojola
for providing the skunks, and Jeff Root for
critical review of early drafts of this
manuscript.
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